US equities |
NVDA $204.64 ▼-4.22% INTC $65.76 ▼-28.58% MU $884.74 ▼-5.30% AMZN $240.35 ▼-1.41% AAPL $344.63 ▼-1.23% SNDK $1,150.89 ▼-13.47% AMD $504.80 ▼-10.88% MSFT $521.91 ▼-1.55%
FinancialContent

(OP:ACUT)

0.1300 UNCHANGED
Delayed Quote Updated: 11:43 AM EDT, Oct 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ACUT

News headline image
AccuStem Sciences Announces StemPrintER Pilot Study with National Surgical Adjuvant Breast and Bowel Project (NSABP)
Initial study will enable further collaboration on the predictive capabilities of StemPrintER 
From AccuStem Sciences, Inc.
Via GlobeNewswire
News headline image
Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
AccuStem Sciences and EmeritusDX Expand Blood-Based Testing Capabilities to Advance Cancer Diagnostics and Treatment Planning
From AccuStem Sciences, Inc.
Via GlobeNewswire
News headline image
Life Science Virtual Investor Forum Agenda Announced for September 18th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
AccuStem Sciences to Present at the Life Sciences Virtual Investor Forum September 18th
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
From AccuStem Sciences, Inc.
Via GlobeNewswire
News headline image
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
From AccuStem Sciences, Inc.
Via GlobeNewswire
News headline image
AccuStem Sciences, Inc. and EmeritusDX Announce Partnership to Commercialize MSC Test for Lung Cancer Screening
From AccuStem Sciences, Inc.
Via GlobeNewswire
News headline image
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
From AccuStem Sciences, Inc.
Via GlobeNewswire
News headline image
AccuStem Sciences, Inc. Signs Agreement to Access Blood Samples from Lung Cancer Screening Trial to Expedite MSC Commercialization Plan
From AccuStem Sciences, Inc.
Via GlobeNewswire
News headline image
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
From AccuStem Sciences, Inc.
Via GlobeNewswire
News headline image
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
From AccuStem Sciences, Inc.
Via GlobeNewswire
News headline image
AccuStem Sciences to Offer its MSC Blood Test to Lung Cancer Screening Programs in the United States
From AccuStem Sciences, Inc.
Via GlobeNewswire
News headline image
AccuStem Sciences, Inc. Announces Acquisition of Proprietary MSC Lung Cancer Screening Test
From AccuStem Sciences, Inc.
Via GlobeNewswire
News headline image
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
From AccuStem Sciences, Inc
Via GlobeNewswire
News headline image
AccuStem Sciences, Inc. and EmeritusDX Announce Joint Product Development Agreement and Strategic Partnership
From AccuStem Sciences, Inc
Via GlobeNewswire
News headline image
AccuStem Sciences, Inc. Extends and Broadens Partnership with Instituto Europeo di Oncologia (IEO) Enabling its Strategic Approach to Address Unanswered Clinical Questions in Early Stage Breast Cancer
From AccuStem Sciences, Inc
Via GlobeNewswire
News headline image
Goldman Small Cap Research Publishes New Research Report on AccuStem Sciences, Inc.
Via ACCESSWIRE
News headline image
AccuStem Sciences, Inc. Announces Collaboration Agreement with University Hospitals
From AccuStem Sciences, Inc.
Via GlobeNewswire
News headline image
AccuStem Announce Strategic Clinical and Operational Partnership
From AccuStem Sciences, Inc.
Via GlobeNewswire
News headline image
AccuStem Sciences Announces Extension of its US Patent Application for SPARE Test for Patients with Breast Cancer
From AccuStem Sciences, Inc.
Via GlobeNewswire
News headline image
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
From AccuStem Sciences, Inc.
Via GlobeNewswire
News headline image
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
From AccuStem Sciences, Inc.
Via GlobeNewswire
News headline image
AccuStem Sciences Announces Appointment of Sean McDonald to Board of Directors
From AccuStem Sciences, Inc.
Via GlobeNewswire
News headline image
AccuStem Announces Adjournment of Annual Meeting of Stockholders
From AccuStem Sciences, Inc.
Via GlobeNewswire
News headline image
4 Stocks Under $2 Insiders Are Aggressively Buying ↗
US crude oil futures traded lower this morning on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern... 
Via Benzinga